TELEFLEX INCORPORATED Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease)
TELEFLEX INCORPORATED (TFX) reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) of -$29.95 million for the 6-month period ending 2020-06-28, per its 10-Q filed 2020-07-30.
Discontinued › Notes › Fair Value Disclosures
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease · last filed 2020-07-30
- TELEFLEX INCORPORATED fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, period increase (decrease) for the quarter ending 2020-06-28 was $16.55M, a 33.49% increase year-over-year.
- TELEFLEX INCORPORATED fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, period increase (decrease) for the quarter ending 2020-03-29 was -$46.50M, a 456.15% decline year-over-year.
- TELEFLEX INCORPORATED fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, period increase (decrease) for the quarter ending 2019-12-31 was -$94.81M.
- TELEFLEX INCORPORATED fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, period increase (decrease) for the quarter ending 2019-09-29 was $15.44M, a 21.31% increase year-over-year.
- TELEFLEX INCORPORATED fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, period increase (decrease) for fiscal 2019 was -$53.91M.
- TELEFLEX INCORPORATED fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, period increase (decrease) for fiscal 2018 was -$52.98M.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) 3 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) 6 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) 9 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) 12 month |
|---|---|---|---|---|
| 2020-06-28 | $16.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30 | -$29.95M 10-Q · filed 2020-07-30 | -$124.76M derived: sum of 3 quarters · filed 2020-07-30 | -$109.32M derived: sum of 4 quarters · filed 2020-07-30 |
| 2020-03-29 | -$46.50M 10-Q · filed 2020-04-30 | -$141.31M derived: sum of 2 quarters · filed 2020-04-30 | -$125.87M derived: sum of 3 quarters · filed 2020-04-30 | -$113.47M derived: sum of 4 quarters · filed 2020-04-30 |
| 2019-12-31 | -$94.81M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-21 | -$79.37M derived: sum of 2 quarters · filed 2020-02-21 | -$66.97M derived: sum of 3 quarters · filed 2020-02-21 | -$53.91M 10-K · filed 2020-02-21 |
| 2019-09-29 | $15.44M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $27.84M derived: sum of 2 quarters · filed 2019-10-31 | $40.89M 10-Q · filed 2019-10-31 | -$59.43M derived: sum of 4 quarters · filed 2020-02-21 |
| 2019-06-30 | $12.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $25.46M 10-Q · filed 2019-08-01 | -$74.86M derived: sum of 3 quarters · filed 2020-02-21 | -$62.14M derived: sum of 4 quarters · filed 2020-02-21 |
| 2019-03-31 | $13.06M 10-Q · filed 2019-05-02 | -$87.26M derived: sum of 2 quarters · filed 2020-02-21 | -$74.54M derived: sum of 3 quarters · filed 2020-02-21 | -$49.51M derived: sum of 4 quarters · filed 2020-02-21 |
| 2018-12-31 | -$100.32M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-21 | -$87.59M derived: sum of 2 quarters · filed 2020-02-21 | -$62.57M derived: sum of 3 quarters · filed 2020-02-21 | -$52.98M 10-K · filed 2020-02-21 |
| 2018-09-30 | $12.73M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $37.75M derived: sum of 2 quarters · filed 2018-11-01 | $47.34M 10-Q · filed 2018-11-01 | |
| 2018-07-01 | $25.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $34.62M 10-Q · filed 2018-08-02 | ||
| 2018-04-01 | $9.59M 10-Q · filed 2018-05-03 | |||
| 2017-10-01 | $128.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | -$288.00K derived: sum of 2 quarters · filed 2017-11-02 | -$109.00K 10-Q · filed 2017-11-02 | |
| 2017-07-02 | -$416.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | -$237.00K 10-Q · filed 2017-08-03 | ||
| 2017-04-02 | $179.00K 10-Q · filed 2017-05-04 | |||
| 2016-09-25 | $430.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-27 | $1.29M derived: sum of 2 quarters · filed 2016-10-27 | $1.67M 10-Q · filed 2016-10-27 | |
| 2016-06-26 | $865.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-28 | $1.24M 10-Q · filed 2016-07-28 | ||
| 2016-03-27 | $377.00K 10-Q · filed 2016-04-28 | |||
| 2015-09-27 | -$951.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-29 | -$3.63M derived: sum of 2 quarters · filed 2015-10-29 | -$3.23M 10-Q · filed 2015-10-29 | |
| 2015-06-28 | -$2.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-30 | -$2.28M 10-Q · filed 2015-07-30 | ||
| 2015-03-29 | $392.00K 10-Q · filed 2015-04-30 | |||
| 2014-09-28 | -$7.67M 10-Q · filed 2014-10-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |